GB Patent

GB2079270A — Imidazo-rifamycin derivatives

Assigned to Alfa Farmaceutici SpA · Expires 1982-01-20 · 44y expired

What this patent protects

Patent listed against Xifaxan.

Drugs covered by this patent

Xifaxan (rifaximin) · Bausch Health

Patent Metadata

Patent number: GB2079270A
Jurisdiction: GB
Classification: —
Expires: 1982-01-20
Drug substance claim: No
Drug product claim: No
Assignee: Alfa Farmaceutici SpA
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.